脑小血管疾病中的TRPV4:一个关键的交互合作伙伴
Sara M P Lambrichts1, Robert J van Oostenbrugge2, Sébastien Foulquier3
1Dept of Pharmacology and Toxicology, Maastricht University, the Netherlands; Dept of Neurology, Maastricht University Medical Center, the Netherlands; MHeNS, Mental Health and Neuroscience Research institute, Maastricht University, the Netherlands.
Vascular pharmacology
|March 20, 2025
概括
暂时受体潜在化物4 (TRPV4) 通道与大脑小血管疾病 (cSVD) 有关,这是血管痴呆的原因. 了解TRPV4在神经血管单元中的作用是开发新治疗cSVD的关键.
科学领域:
- 神经科学是一个神经科学.
- 血管生物学 血管生物学
- 机械生物学 机械生物学
背景情况:
- 大脑小血管疾病 (cSVD) 是血管认知障碍和痴呆的主要原因.
- cSVD的发病包括神经血管单元功能障碍,包括血脑屏障 (BBB) 损伤,脑血管反应能力降低和低.
- 神经血管单元中的机械敏感离子通道对于这些过程至关重要.
研究的目的:
- 审查神经血管单元内的短暂受体潜在化物4 (TRPV4) 通道的多方面的作用.
- 探索TRPV4与分子伙伴的相互作用.
- 讨论TRPV4对cSVD病理生理学的潜在贡献.
主要方法:
- 文献综述专注于大脑微血管的机械生物学.
- 对TRPV4生理和病理作用的最新证据的分析.
- 综合与TRPV4和cSVD机制相关的发现.
主要成果:
- TRPV4通道调节关键的生理功能:血管度,血管生成,BBB完整性和神经炎症.
- TRPV4涉及病理过程,包括大脑血管重塑,反应能力受损和BBB功能障碍.
- TRPV4通道在神经血管单元的细胞中表达,这表明它在cSVD中发挥了直接作用.
结论:
- TRPV4在神经血管单元的正常功能中起着重要作用.
- 对TRPV4的失调有助于在cSVD中观察到的病理变化.
- 向TRPV4可能为管理cSVD和相关认知衰退提供治疗策略.
相关概念视频
00:49The Blood-brain Barrier
47.4K
Overview
47.4K
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
1.2K
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
1.2K
01:16Vascular Spasm
4.9K
The vascular phase, also known as vasospasm, is the initial stage of hemostasis, crucial for preventing excessive bleeding when a blood vessel is injured. After a vessel is cut, nerves in the damaged area trigger pain and other sensory impulses. Simultaneously, the smooth muscles in the vessel wall contract, resulting in a vascular spasm. This contraction reduces the vessel's diameter at the injury site, slowing or stopping blood loss through the vessel wall. Vascular spasms typically last...
4.9K
01:15Ischemic Stroke ll: Pathophysiology
68
An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
68
01:29Hemorrhagic Stroke ll: Pathophysiology
52
A hemorrhagic stroke develops when a cerebral blood vessel ruptures, allowing blood to escape into the surrounding brain tissue, as in intracerebral hemorrhage (ICH), or into the subarachnoid space, as in subarachnoid hemorrhage (SAH). Because the skull is a rigid compartment, the sudden presence of extravascular blood rapidly increases intracranial pressure and compresses adjacent neural structures, leading to immediate tissue injury and impaired cerebral perfusion.Mass Effect and Primary...
52
01:22Cerebral Edema ll: Pathophysiology
31
Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this...
31